Analogs of 5-(substituted benzylidene)hydantoin as inhibitors of tyrosinase and melanin formation.
暂无分享,去创建一个
Ji Min Kim | Daeui Park | Eun Kyeong Lee | Hae Young Chung | Daeui Park | H. Chung | H. Moon | K. Chung | E. Lee | Y. Ha | Ji Young Park | Jeong‐Hyun Yoon | Young Mi Ha | Yun Jung Park | Hye Jin Lee | Hyung Ryong Moon | Ji Yeon Lee | Jin-Ah Kim | Jeong Hyun Yoon | Ki Wung Chung | Jin-ah Kim | Y. Park | Ji min Kim | Ji Min Kim | Jin-Ah Kim
[1] H. Chung,et al. 4,4'-Dihydroxybiphenyl as a new potent tyrosinase inhibitor. , 2005, Biological & pharmaceutical bulletin.
[2] J. Na,et al. Inhibitory effects of 4-n-butylresorcinol on tyrosinase activity and melanin synthesis. , 2005, Biological & pharmaceutical bulletin.
[3] K. Rangappa,et al. Synthesis and antiproliferative activity of substituted diazaspiro hydantoins: a structure–activity relationship study , 2009, Investigational New Drugs.
[4] Youngsoo Kim,et al. Oxyresveratrol and Hydroxystilbene Compounds , 2002, The Journal of Biological Chemistry.
[5] J. Menéndez,et al. Synthesis, Anticonvulsant and Antihypertensive Activity of Diastereomeric 9,10-Dimethoxy-1,3,4,6,7,11b-hexahydrospiro(benzo(a) quinolizin-2,4′-imidazolidine)-2′,5′-diones. , 1992 .
[6] H. M. Kim,et al. Hydantoin derivative formation from oxidation of 7,8-dihydro-8-oxo-2'-deoxyguanosine (8-oxodG) and incorporation of 14C-labeled 8-oxodG into the DNA of human breast cancer cells. , 2005, Bioorganic & medicinal chemistry letters.
[7] A. Ahlhelm,et al. [Racemates and enantiomers of basic, substituted 5-phenylhydantoins, synthesis and anti-arrhythmic action]. , 1997, Die Pharmazie.
[8] S. H. Kang,et al. Oxyresveratrol as the potent inhibitor on dopa oxidase activity of mushroom tyrosinase. , 1998, Biochemical and biophysical research communications.
[9] Torsten Schwede,et al. BIOINFORMATICS Bioinformatics Advance Access published November 12, 2005 The SWISS-MODEL Workspace: A web-based environment for protein structure homology modelling , 2022 .
[10] R. Glen,et al. Synthesis and serotonergic activity of substituted 2, N-benzylcarboxamido-5-(2-ethyl-1-dioxoimidazolidinyl)-N, N-dimethyltryptamine derivatives: novel antagonists for the vascular 5-HT(1B)-like receptor. , 1999, Journal of medicinal chemistry.
[11] Hwan-Suck Chung,et al. Naturally occurring tyrosinase inhibitors: mechanism and applications in skin health, cosmetics and agriculture industries , 2007, Phytotherapy research : PTR.
[12] I. Kubo,et al. Flavonols from Heterotheca inuloides: tyrosinase inhibitory activity and structural criteria. , 2000, Bioorganic & medicinal chemistry.
[13] H. Chung,et al. Inhibition of tyrosinase by protocatechuic aldehyde. , 2004, The American journal of Chinese medicine.
[14] V. Kahn,et al. Effect of methimazole on the activity of mushroom tyrosinase. , 1986, The Biochemical journal.
[15] B. Tóth,et al. Synthesis of and a comparative study on the inhibition of muscle and liver glycogen phosphorylases by epimeric pairs of d-gluco- and d-xylopyranosylidene-spiro-(thio)hydantoins and N-(d-glucopyranosyl) amides. , 2001, Journal of medicinal chemistry.
[16] E. Camera,et al. Chemical and instrumental approaches to treat hyperpigmentation. , 2003, Pigment cell research.
[17] G. Martin,et al. A novel series of 2,5-substituted tryptamine derivatives as vascular 5HT1B/1D receptor antagonists. , 1997, Journal of medicinal chemistry.
[18] A. Khodair. Synthesis of arylidenehydrazono- and glycopyranosylhydrazino-sulfonylbenzylidene-2,4-imidazolidinediones as potential antiviral and antitumoral agents. , 1998, Carbohydrate research.
[19] R. Reynolds,et al. 5,5-disubstituted hydantoins: syntheses and anti-HIV activity. , 1992, Journal of medicinal chemistry.
[20] L. Frye,et al. Binding site elucidation of hydantoin-based antagonists of LFA-1 using multidisciplinary technologies: evidence for the allosteric inhibition of a protein--protein interaction. , 2001, Journal of the American Chemical Society.
[21] C. Bertolotto,et al. BMP-2 stimulates tyrosinase gene expression and melanogenesis in differentiated melanocytes. , 2001, Pigment cell research.
[22] Jae-Kwan Hwang,et al. Inhibitory effects of active compounds isolated from safflower (Carthamus tinctorius L.) seeds for melanogenesis. , 2004, Biological & pharmaceutical bulletin.
[23] E. Monzani,et al. Inhibition of the catecholase activity of biomimetic dinuclear copper complexes by kojic acid , 2000, JBIC Journal of Biological Inorganic Chemistry.
[24] J. Nordlund. The pigmentary system : physiology and pathophysiology , 1998 .
[25] Wolfgang Löscher,et al. Hydantoin-substituted 4,6-dichloroindole-2-carboxylic acids as ligands with high affinity for the glycine binding site of the NMDA receptor. , 2003, Journal of medicinal chemistry.
[26] V. Hearing,et al. Enzymatic control of pigmentation in mammals , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[27] Kenji Matsumoto,et al. Gnetol as a Potent Tyrosinase Inhibitor from Genus Gnetum , 2003, Bioscience, biotechnology, and biochemistry.
[28] Jun Sik Lee,et al. Antimelanogenic Activity of 3,4-Dihydroxyacetophenone: Inhibition of Tyrosinase and MITF , 2006, Bioscience, biotechnology, and biochemistry.
[29] C. A. Ramsden,et al. Evidence of the Indirect Formation of the Catecholic Intermediate Substrate Responsible for the Autoactivation Kinetics of Tyrosinase* , 1997, The Journal of Biological Chemistry.
[30] P. Wong,et al. Anticonvulsant activity of phenylmethylenehydantoins: a structure-activity relationship study. , 2004, Journal of medicinal chemistry.
[31] Tirso Pons,et al. Homology modeling, model and software evaluation: three related resources , 1998, Bioinform..
[32] S. Rhee,et al. Inhibition of tyrosinase by green tea components. , 1999, Life sciences.
[33] T. Igarashi,et al. Synthesis and antiarrhythmic activity of 2,2-dialkyl-1'-(N-substituted aminoalkyl)-spiro-(chroman-4,4'-imidazolidine)-2',5'-diones. , 1992, Chemical & pharmaceutical bulletin.
[34] M. Fukuda,et al. Arbutin: mechanism of its depigmenting action in human melanocyte culture. , 1996, The Journal of pharmacology and experimental therapeutics.
[35] H. Chung,et al. 4-(6-Hydroxy-2-naphthyl)-1,3-bezendiol: a potent, new tyrosinase inhibitor. , 2007, Biological & pharmaceutical bulletin.
[36] F. García-Cánovas,et al. Effect of L-ascorbic acid on the monophenolase activity of tyrosinase. , 1993, The Biochemical journal.
[37] M. Mor,et al. 5-benzylidene-hydantoins as new EGFR inhibitors with antiproliferative activity. , 2006, Bioorganic & medicinal chemistry letters.
[38] T. Pedley,et al. Advances in the medical treatment of epilepsy. , 1998, Annual review of medicine.
[39] J. Menéndez,et al. Synthesis, anticonvulsant and antihypertensive activity of diastereomeric 9,10-dimethoxy-1,3,4,6,7,11b-hexahydrospiro-[benzo[a]quinolizin-2,4-imidazolidine]2',5'-diones , 1992 .
[40] M. Koyama,et al. An improved colorimetric assay for interleukin 2. , 1986, Journal of immunological methods.
[41] Irwin D. Kuntz,et al. Development and validation of a modular, extensible docking program: DOCK 5 , 2006, J. Comput. Aided Mol. Des..
[42] J. Chung,et al. Delayed ERK activation by ceramide reduces melanin synthesis in human melanocytes. , 2002, Cellular signalling.
[43] A. Nias,et al. Effect of azelaic acid on melanoma cells in culture , 1995, Experimental dermatology.
[44] J. Knabe,et al. Razemate und Enantiomere basisch substituierter 5-Phenylhydantoine, Synthese und antiarrhythmische Wirkung , 1997 .
[45] Tetsuro Ito,et al. Inhibitory Effects of Resveratrol Derivatives from Dipterocarpaceae Plants on Tyrosinase Activity , 2003, Bioscience, biotechnology, and biochemistry.
[46] A. Markovac,et al. Hydantoins as antitumor agents. , 1977, Journal of medicinal chemistry.
[47] Francisco Solano,et al. Hypopigmenting agents: an updated review on biological, chemical and clinical aspects. , 2006, Pigment cell research.